This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one dose. By combining two immune-boosting adjuvants alum and SMNP the vaccine lingers in lymph nodes for nearly a month, encouraging the body to produce a vast array of antibodies. This one-shot strategy could revolutionize how we fight not just HIV, but many infectious diseases.
ABSTRACT Fused pyrimidine scaffolds serve as a flexible and versatile foundational heterocycle in the field of pharmaceutical development. Thienopyrimidines are a diverse family of molecules characterized by the fusion of a thieno ring with a pyrimidine moiety, resulting in a unique scaffold with promising chemical and pharmacological properties. Thienopyrimidines exhibit multifarious features, mainly, this is due to their structural resemblance with purine bases, such as guanine and adenine.
In the field of drug discovery, few areas face a more pressing need for innovation than pain management. For decades, opioids have dominated the space, but despite their effectiveness they are burdened by significant risks of dependence and misuse. As the limitations of current treatments become increasingly clear, researchers are exploring new, safer approaches.
DLL3, B7H3 and Her3 are compelling tumor antigens to target with cancer therapeutics. They have interesting patterns of expression in different cancer indications; thus, diverse therapies for attacking these targets have been developed. Each target and each therapeutic modality induce varying degrees of clinical efficacy, as well as causing toxicities.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
As funding becomes increasingly scarce and timelines grow tighter, life science researchers are re-evaluating how they operate. James Atwood, Chief Operating Officer of lab robotics company Opentrons , believes automation is the leveller that could reshape scientific discovery from the ground up. With a background spanning biopharma leadership, genomics and technology commercialisation, Atwood is helping to drive a shift towards more efficient and flexible lab operations.
Clinical trials rely on comprehensive data collection to prove the investigational drug/device’s efficacy and safety, the Case Report Form (CRF), a structured document designed to record all trial-related data for each participant makes this possible. However, simply collecting data isn't enough, it must be clearly mapped to datasets required for regulatory submission, and that's where annotated CRFs (aCRFs) come in.
Researchers investigating the enigmatic and antibiotic-resistant Pandoraea bacteria have uncovered a surprising twist: these pathogens don't just pose risks they also produce powerful natural compounds. By studying a newly discovered gene cluster called pan, scientists identified two novel molecules Pandorabactin A and B that allow the bacteria to steal iron from their environment, giving them a survival edge in iron-poor places like the human body.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Researchers investigating the enigmatic and antibiotic-resistant Pandoraea bacteria have uncovered a surprising twist: these pathogens don't just pose risks they also produce powerful natural compounds. By studying a newly discovered gene cluster called pan, scientists identified two novel molecules Pandorabactin A and B that allow the bacteria to steal iron from their environment, giving them a survival edge in iron-poor places like the human body.
Grifols’ BT524 Fibrinogen Therapy Shows Promise in Phase 3 Trial Published in The Lancet’s eClinicalMedicine Grifols , a globally recognized healthcare company and a leader in the production of plasma-derived therapies, has marked a significant advancement in the treatment of acquired fibrinogen deficiency (AFD). The company recently announced the publication of positive Phase 3 clinical trial results for its investigational fibrinogen concentrate, BT524, in eClinicalMedicine , a prestigio
With $860K in Navy funding, MSU psychologists are developing tools to spot people who can handle complex tasks under pressure. The key? Mastering "placekeeping" staying focused and accurate even when sleep-deprived or interrupted.
Rebuilding Trust and Reshaping Global Health Finance: H20 Summit Lays Groundwork for G20 Health Agenda From June 19 to 20, global leaders in health and development converged in Geneva for the annual Health20 (H20) Summit. The high-level event, organized by the G20 Health & Development Partnership and co-hosted by the World Health Organization (WHO), brought together G20 policymakers, international health experts, and key private and public sector stakeholders to reimagine the future of globa
This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors. Click here to see the original post from April 2025. It's time for Drug Channels ’ annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services within U.S. drug channels.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Civil Society Deepens Its Role in Shaping Global Health Policy at WHA78 At the 78th World Health Assembly (WHA78), held under the unifying theme “One World for Health,” a pivotal shift in the dynamics of global health governance was unmistakably evident. As delegates from World Health Organization (WHO) Member States and key stakeholders converged to tackle urgent public health challenges—including the Pandemic Agreement, antimicrobial resistance (AMR), climate-induced health risks,
THURSDAY, June 19, 2025 — Drinking a cup or two of coffee every day may help you live longer — but only if you skip the heavy cream and sugar, new research suggests. The research, published recently in The Journal of Nutrition, found.
AI researchers in Switzerland have found a way to dramatically cut cement s carbon footprint by redesigning its recipe. Their system simulates thousands of ingredient combinations, pinpointing those that keep cement strong while emitting far less CO2 all in seconds.
THURSDAY, June 19, 2025 — As summer temperatures rise, a Houston emergency room doctor is sharing important tips to help folks stay safe while outdoors. Dr. Neil Gandhi, an emergency medicine physician with Houston Methodist, says a mix of.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Astronomers have uncovered a colossal, searing-hot filament of gas linking four galaxy clusters in the Shapley Supercluster a discovery that could finally solve the mystery of the Universe s missing matter. This giant thread, 10 times the mass of the Milky Way and stretching 23 million light-years, is one of the best confirmations yet of what cosmological simulations have long predicted: that vast, faint filaments connect the Universe s largest structures in a cosmic web.
Can you believe it’s already June ? As we move further into 2025, it’s a perfect time to reflect on the journey we’ve taken thus far, including the wins, generosity, and impactful moments that have defined our incredible colleague community. Encouraging The Spirit of Giving At Perficient The kindness of our colleagues is unmatched, and Perficient’s Giving Employee Resource Group (ERG) sets a shining example of dedication and generosity for others around the world.
During Earth's ancient Snowball periods, when the entire planet was wrapped in ice, life may have endured in tiny meltwater ponds on the surface of equatorial glaciers. MIT researchers discovered that these watery refuges could have supported complex eukaryotic life, serving as sanctuaries for survival amid extreme conditions. Their investigation into Antarctic melt ponds revealed not only evidence of eukaryotes but a striking diversity shaped by factors like salinity.
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
The Great Marketing Evolution Marketing today is no longer about sending the right message —it’s about delivering that message at the right moment. Customers expect brands to anticipate their needs, adapt quickly, and deliver personalized experiences without feeling intrusive. The companies that succeed? They’re not guessing. They’re using data and automation to stay ahead.
In existence since just July of 2019, the Pan African Payment and Settlement System (PAPSS) has in many ways surpassed the payment and settlement process of the western banking world. PAPSS enables the efficient flow of money securely across African borders to minimize risk and thereby contributing to financial integration of the African continent. PAPSS core service is provided by the PAPSS Instant Payment system (“PIP”).
Angular Signals State Management is a new, built-in approach that simplifies state handling in Angular. Unlike RxJS or NgRx, Signals offer an intuitive, reactive, and efficient way to manage state with automatic dependency tracking and reduced re-renders. What Are Signals in Angular? Signals in Angular represent a new reactivity model that allows you to track and update state efficiently.
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Angular Signals State Management is a new, built-in approach that simplifies state handling in Angular. Unlike RxJS or NgRx, Signals offer an intuitive, reactive, and efficient way to manage state with automatic dependency tracking and reduced re-renders. What Are Signals in Angular? Signals in Angular represent a new reactivity model that allows you to track and update state efficiently.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content